| 1. |
Jenkins, M. K., Pardoll, D. M., Mizuguchi, J., Quill, H., and Schwartz, R. H. (1987) T-cell unresponsiveness in vivo and in
vitro: fine specificity of induction and molecular characterization of the unresponsive state. Immunol. Rev.
95, 113–135.
|
| |
| 2. |
Schwartz, R. H. (1990) A cell culture model for T lymphocyte clonal anergy. Science
248(4961), 1349–1356.
|
| |
| 3. |
Matzinger, P. (1999) Graft tolerance: a duel of two signals. Nat. Med.
5, 616–617.
|
| |
| 4. |
Gimmi, C. D., Freeman, G. J., Gribben, G. J., Gray, G., and Nadler, L. M. (1993) Human T-cell clonal anergy is induced by
antigen presentation in the absence of B7 costimulation. Proc Natl Acad Sci USA
90(14), 6586–6590.
|
| |
| 5. |
Greenwald, R. J., Boussiotis, V. A., Lorsbach, R. B., Abbas, A. K., and Sharpe, A. H. (2001) CTLA-4 regulates induction of
anergy in vivo. Immunity
14(2), 145–155.
|
| |
| 6. |
Wells, A. D., Walsh, M. C., Bluestone, J. A., and Turka, L. A. (2001) Signaling through CD28 and CTLA-4 controls two distinct
forms of T cell anergy. J. Clin. Invest.
108(6), 895–904.
|
| |
| 7. |
Frauwirth, K. A., Alegre, M. L., and Thompson, C. B. (2000) Induction of T cell anergy in the absence of CTLA-4/B7 interaction.
J. Immunol.
164(6), 2987–2993.
|
| |
| 8. |
Li, Y., Li, X. C., Zheng, X. X., Wells, A. D., Turka, L. A., and Strom, T. B. (1999) Blocking both signal 1 and signal 2 of
T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance. Nat. Med.
5(11), 1298-1302.
|
| |
| 9. |
Azuma, M., Cayabyab, M., Buck, D., Phillips, J. H., and Lanier, L. L. (1992) CD28 interaction with B7 costimulates primary
allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes. J. Exp. Med.
175(2), 353–360.
|
| |
| 10. |
Larsen, C. P., Elwood, E. T., Alexander, D. Z., et al. (1996) Long-term acceptance of skin and cardiac allografts after blocking
CD40 and CD28 pathways. Nature
381(6581), 434–438.
|
| |
| 11. |
Kirk, A. D., Harlan, D. M., Armstrong, N. N., et al. (1997) CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection
in primates. Proc. Natl. Acad. Sci. USA
94(16), 8789–8794.
|
| |
| 12. |
Cayabyab, M., Phillips, J. H., and Lanier, L. L. (1994) CD40 preferentially costimulates activation of CD4+T lymphocytes.
J. Immunol.
152(4), 1523–1531.
|
| |
| 13. |
Croft, M. (2003) Costimulation of T cells by OX40, 4-1BB, and CD27. Cytokine Growth Factor Rev.
14(3-4), 265–273.
|
| |
| 14. |
Hutloff, A., Dittrich, A. M., Beier, K. C., et al. (1999) ICOS is an inducible T-cell co-stimulator structurally and functionally
related to CD28. Nature
397(6716), 263–266.
|
| |
| 15. |
Mallett, S., Fossum, S., and Barclay, A. N. (1990) Characterization of the MRC OX40 antigen of activated CD4 positive T lymphocytes-a
molecule related to nerve growth factor receptor. EMBO J.
9(4), 1063–1068.
|
| |
| 16. |
de Jong, R., Loenen, W. A., Brouwer, M., et al. (1991) Regulation of expression of CD27, a T cell-specific member of a novel
family of membrane receptors. J. Immunol.
146(8), 2488–2494.
|
| |
| 17. |
Kim, Y. J., Pollok, K. E., Zhou, Z., et al. (1993) Novel T cell antigen 4-1BB associates with the protein tyrosine kinase
p56lck1. J. Immunol.
151(3), 1255–1262.
|
| |
| 18. |
Del Prete, G., De Carli, M., D’Elios, M. M., et al. (1995) CD30-mediated signaling promotes the development of human T helper
type 2-like T cells. J. Exp. Med.
182(6), 1655–1661.
|
| |
| 19. |
Kobata, T., Agematsu, K., Kameoka, J., Schlossman, S. F., and Morimoto, C. (1994) CD27 is a signal-transducing molecule involved
in CD45RA+naive T cell costimulation. J. Immunol.
153(12), 5422–5432.
|
| |
| 20. |
Demirci, G., Gao, W., Zheng, X. X., Malek, T. R., Strom, T. B., and Li, X. C. (2002) On CD28/CD40 ligand costimulation, common
gamma-chain signals, and the alloimmune response. J. Immunol.
168(9), 4382–4390.
|
| |
| 21. |
Lyons A.B. (2000) Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution. J. Immunol. Methods
243(1-2), 147–154.
|
| |
| 22. |
Lyons, A. B. (1999) Divided we stand: tracking cell proliferation with carboxyfluorescein diacetate succinimidyl ester. Immunol. Cell Biol.
77(6), 509–515.
|
| |
| 23. |
Lyons, A. B. and Parish, C. R. (1994) Determination of lymphocyte division by flow cytometry. J. Immunol. Methods
171(1), 131–137.
|
| |
| 24. |
Wells, A. D., Gudmundsdottir, H., and Turka, L. A. (1997) Following the fate of individual T cells throughout activation and
clonal expansion. J. Clin. Invest.
100(12), 3173–3183.
|
| |
| 25. |
Fulcher, D. and Wong, S. (1999) Carboxyfluorescein succinimidyl ester-based prolifera-tive assays for assessment of T cell
function in the diagnostic laboratory. Immunol. Cell Biol.
77(6), 559–564.
|
| |
| 26. |
Weston, S. A. and Parish, C. R. (1990) New fluorescent dyes for lymphocyte migration studies. J. Immunol. Methods
133(1), 87–97.
|
| |
| 27. |
Parish, C. R. (1999) Fluorescent dyes for lymphocyte migration and proliferation studies. Immunol. Cell Biol.
77(6), 499–508.
|
| |
| 28. |
Kruisbeek, A. M. (2000) In vitro assays for mouse lymphocyte function, In: Current Protocols in Immunology. Coligan, J. E., Kruisbeek, A. M., Margulies, D. H., Shevack, E. M., and Strober, W. (eds). National Institutes of Health,
Wiley, New York, NY, pp. 3.1.1–3.1.5.
|
| |
| 29. |
van Oss, C. J., Bronson, P. M., Dinolfo, E. A., and Chadha, K. C. (1981) Two methods for the removal of erythrocytes from
buffy coats for the production of human leukocyte inter-feron. Immunol. Commun.
10(6), 549–555.
|
| |
| 30. |
Drake, D. R. 3rd. and Braciale, T. J. (2003) Not all effector CD8+T cells are alike. Microbes Infect.
5(3), 199–204.
|
| |
| 31. |
Cron, R. Q., Gajewski, T. F., Sharrow, S. O., Fitch, F. W., Matis, L. A., and Bluestone, J. A. (1989) Phenotypic and functional
analysis of murine CD3+,CD4-,CD8-TCR-gamma delta-expressing peripheral T cells. J. Immunol.
142(11), 3754–3762.
|
| |